查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1478005

多重檢測免疫分析市場：依產品類型、最終用戶、地區 - 全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031 年

Multiplex Detection Immunoassay Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 228 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本研究報告是 Persistence Market Research 的市場研究報告，對全球多重檢測免疫分析市場進行了詳細的分析和預測。 這份綜合報告提供了關鍵市場動態、市場成長驅動因素、課題和新興趨勢的寶貴見解。 它詳細概述了醫療保健和生命科學行業的多重檢測免疫分析領域，提供了獨家數據和統計數據來預測 2024 年至 2031 年的市場成長軌跡。

關鍵見解

  • 多重檢測免疫分析市場規模（2024 年）：30.35 億美元
  • 預測市場價值（2031 年）65.02 億美元
  • 全球市場成長率（複合年增長率，2024-2031 年）：4.2%

多重檢測免疫分析市場 - 報告範圍：

多重檢測免疫分析市場涵蓋臨床診斷、藥物發現和生物標記研究中使用的各種產品、技術和應用。 該市場為臨床實驗室、製藥公司、生物技術公司和學術研究機構提供多重檢測免疫分析平台和分析方法，用於同時檢測和定量單一樣本中的多種分析物。 多重檢測免疫分析能夠對生物標記、細胞激素、蛋白質和抗體進行高通量分析，有助於全面分析疾病狀態、藥物反應和免疫功能。 市場成長是由對個人化醫療、精準診斷和生物標記驅動療法的需求不斷增長，以及免疫分析技術和分析設計的進步所推動的。

推動市場成長的因素：

全球多重檢測免疫分析市場正受益於幾個關鍵的市場成長驅動因素。 慢性病、傳染病和癌症的流行正在推動對用於早期檢測、診斷和監測疾病進展的多重免疫測定解決方案的需求。 此外，檢測靈敏度、特異性和多重功能的進步使研究人員能夠以更高的精度和準確度分析複雜的生物樣品。 此外，多重檢測免疫分析平台在臨床試驗、伴隨診斷和個人化醫療計劃中的採用正在推動市場擴張。 此外，對生物標記發現、患者分層和藥物基因組學研究的日益關注，為轉化醫學和精準腫瘤學中的多重免疫分析應用創造了機會。

市場限制因素：

儘管成長前景廣闊，但多重檢測免疫分析市場仍面臨分析標準化、驗證和監管合規性的課題。 多重檢測免疫測定缺乏標準化方案和參考材料，這可能促使測定性能和結果解釋的可變性，影響研究和實驗室之間的再現性和可比性。 此外，對測定特異性、交叉反應性和內源性物質幹擾的擔憂可能會影響多重免疫測定的測量準確性和可靠性。 此外，檢測驗證、品質控制和臨床效用評估的監管要求對市場進入和商業化提出了課題。 為了解決這些障礙，行業利益相關者、監管機構和標準機構必須共同努力，為多重免疫測定的開發和驗證建立最佳實踐和指南。

市場機會：

由於技術創新、市場擴張和應用多樣化，多重檢測免疫分析市場提供了巨大的成長機會。 單細胞分析、空間分析和多組學整合等新興趨勢為多重免疫分析技術解決複雜的生物學問題和疾病機制提供了新途徑。 高通量免疫分析平台、微流體裝置和即時檢測系統的開發使得能夠在臨床和研究環境中快速且經濟高效地分析生物標記。 此外，精準醫學中伴隨診斷、免疫監測和患者分層的需求不斷增長，為多重免疫分析和平台創造了新的市場機會。 策略夥伴關係、協作以及研發投資對於跟上新興趨勢並維持動態多重檢測免疫分析領域的市場領先地位至關重要。

本報告涵蓋的主要問題

  • 推動多重檢測免疫分析市場全球成長的因素有哪些？
  • 免疫分析技術與分析設計的進步如何改變多重檢測免疫分析的競爭格局？
  • 市場參與者在多重檢測免疫分析領域面臨哪些主要課題與機會？
  • 哪些應用和最終用戶領域對多重檢測免疫分析產品和服務具有最大的成長潛力？
  • 領先公司採取哪些策略來維持市場競爭力並推動創新？

競爭資訊與業務策略：

全球多重檢測免疫分析市場的領導者，包括診斷公司、生物技術公司和生命科學供應商，正在專注於技術創新、產品差異化和市場擴張，以獲得競爭優勢。 這些公司投資研發，開發針對特定臨床和研究應用的下一代多重免疫分析平台、分析方法和試劑。 我們也與意見領袖、臨床研究網絡和製藥公司結成策略聯盟，以驗證產品性能、展示臨床實用性並擴大市場範圍。 此外，我們對客戶支援、技術培訓和科學教育措施的關注提高了免疫分析技術競爭格局中的品牌聲譽和客戶忠誠度。

主要公司簡介：

  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • EMD Millipore (Merck KGaA.)
  • Becton, Dickinson and Company.
  • Microsynth AG
  • Quansys Biosciences Inc
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation.
  • Luminex Corporation

多重檢測免疫分析市場研究細分：

多重偵測免疫分析市場：依技術劃分

  • 基於核酸的技術
  • 基於蛋白質的技術
  • 基於生物感測器的方法

多重檢測免疫分析市場：依分析類型劃分

  • 平面測定
  • 混合蛋白晶片（多重 ELISA）
  • 抗體陣列
  • 基於微珠的檢測
  • 磁珠底座
  • 非磁珠底座

多重偵測免疫分析市場：依應用劃分

  • 疾病檢測
  • 傳染病檢測
  • 自體免疫疾病檢測
  • 其他疾病測試
  • 食品污染檢驗
  • 研究與開發
  • 獸醫疾病檢查

多重檢測免疫分析市場：依最終用戶劃分

  • 製藥公司
  • 臨床研究所
  • 食品和飲料公司
  • 學術研究所
  • 診斷中心
  • 生技中心

多重檢測免疫分析市場：依地區

  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲 (MEA)

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義

第三章市場動態

  • 宏觀經濟因素
  • 促進因素
    • 供應方驅動因素
    • 需求方驅動因素
  • 抑制因素
  • 機會
  • 趨勢

第四章市場狀況

  • 監管場景
  • PEST分析
  • 科技的演變

第五章全球多重檢測免疫分析市場價值分析

  • 過去的市場價值分析，2019-2023 年
  • 當前與未來市場價值預測：2022-2024 年
    • 年成長趨勢分析
    • 絕對數量機會分析

第 6 章全球多重檢測免疫分析市場分析：依分析類型

  • 簡介/主要發現
  • 歷史市場規模分析：依檢測類型，2019-2023 年
  • 2022-2024 年當前及未來市場規模分析及預測（依檢測類型）
    • 平面測定
    • 基於微珠的檢測
  • 市場吸引力分析：依檢測類型

第 7 章全球多重檢測免疫分析市場分析：依技術

  • 簡介/主要發現
  • 過去的市場規模分析：依技術分類，2019-2023 年
  • 當前和未來的市場規模分析和預測：依技術分類，2022-2024 年
    • 基於核酸的技術
    • 基於蛋白質的技術
    • 基於生物感測器的技術
  • 市場吸引力分析：依技術分類

第 8 章全球多重檢測免疫分析市場分析：依應用

  • 簡介/主要發現
  • 過去的市場規模分析：依應用劃分，2019-2023 年
  • 當前和未來的市場規模分析和預測：依應用劃分，2022-2024 年
    • 疾病檢測
    • 食品污染檢驗
    • 研究與開發
    • 獸醫疾病檢查
  • 市場吸引力分析：依應用分類

第 9 章全球多重偵測免疫分析市場分析：依最終使用者劃分

  • 簡介/主要發現
  • 過去的市場規模分析：依最終用戶劃分，2019-2023 年
  • 當前和未來的市場規模分析和預測：依最終用戶劃分，2022-2024 年
    • 製藥公司
    • 臨床研究所
    • 食品和飲料公司
    • 學術研究所
    • 診斷中心
    • 生技中心
  • 市場吸引力分析：依最終用戶分類

第 10 章依地區劃分的全球多重檢測免疫分析市場分析

  • 簡介
  • 過去的市場規模分析：依地區劃分，2019-2023 年
  • 當前市場規模分析與預測：依地區劃分，2022-2024 年
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東/非洲
  • 市場吸引力分析：依地區劃分

第十一章北美多重檢測免疫分析市場分析

第十二章拉丁美洲多重檢測免疫分析市場分析

第13章歐洲多重檢測免疫分析法定市場分析

第十四章南亞多重檢測免疫分析市場分析

第十五章東亞多重檢測免疫分析市場分析

第十六章大洋洲多重檢測免疫分析市場分析

第十七章中東與非洲多重檢測免疫分析市場分析

第十八章新興國家多重檢測免疫分析市場分析

  • 簡介
    • 市值比分析：依主要國家分類
    • 世界與各國成長比較
  • 法國多重檢測免疫分析市場分析
    • 簡介
    • 市場價值分析與預測：依市場分類
      • 依檢測類型
      • 依技術
      • 依用途
      • 依最終用戶
  • 西班牙多重檢測免疫分析市場分析
    • 簡介
    • 市場價值分析與預測：依市場分類
      • 依檢測類型
      • 依技術
      • 依用途
      • 依最終用戶
    • 西班牙多重檢測免疫分析市場 - 競爭格局
  • 日本多重檢測免疫分析市場分析
    • 簡介
    • 市場價值分析與預測：依市場分類
      • 依檢測類型
      • 依技術
      • 依用途
      • 依最終用戶

第19章競爭分析

  • 公司股票分析
  • 競爭對手儀表板
  • 衝突詳情
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific
    • EMD Millipore（Merck KGaA.）
    • Becton, Dickinson and Company.
    • Microsynth AG
    • Quansys Biosciences Inc
    • QIAGEN NV
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation.
    • Luminex Corporation

第 20 章先決條件與使用的縮寫

第21章研究方法

簡介目錄
Product Code: PMRREP11542

Persistence Market Research, a leading market research firm, has conducted an in-depth analysis of the global Multiplex Detection Immunoassay Market. This comprehensive report provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It offers a detailed overview of the multiplex detection immunoassay segment within the healthcare and life sciences industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2031.

Key Insights:

  • Multiplex Detection Immunoassay Market Size (2024): USD3.035 Bn
  • Projected Market Value (2031): USD6.502 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 4.2%

Multiplex Detection Immunoassay Market - Report Scope:

The Multiplex Detection Immunoassay Market encompasses a wide range of products, technologies, and applications used in clinical diagnostics, drug discovery, and biomarker research. This market serves clinical laboratories, pharmaceutical companies, biotechnology firms, and academic research institutions, offering multiplex immunoassay platforms and assays for simultaneous detection and quantification of multiple analytes in a single sample. Multiplex immunoassays enable high-throughput analysis of biomarkers, cytokines, proteins, and antibodies, facilitating comprehensive profiling of disease states, drug responses, and immune function. Market growth is driven by increasing demand for personalized medicine, precision diagnostics, and biomarker-driven therapeutics, as well as advancements in immunoassay technology and assay design.

Market Growth Drivers:

The global Multiplex Detection Immunoassay Market benefits from several key growth drivers. The growing prevalence of chronic diseases, infectious diseases, and cancer fuels demand for multiplex immunoassay solutions for early detection, diagnosis, and monitoring of disease progression. Moreover, advancements in assay sensitivity, specificity, and multiplexing capabilities enable researchers to analyze complex biological samples with greater precision and accuracy. Furthermore, the adoption of multiplex immunoassay platforms in clinical trials, companion diagnostics, and personalized medicine initiatives drives market expansion. Additionally, the increasing focus on biomarker discovery, patient stratification, and pharmacogenomics research creates opportunities for multiplex immunoassay applications in translational medicine and precision oncology.

Market Restraints:

Despite its promising growth prospects, the Multiplex Detection Immunoassay Market faces challenges related to assay standardization, validation, and regulatory compliance. The lack of standardized protocols and reference materials for multiplex immunoassays may lead to variability in assay performance and results interpretation, affecting reproducibility and comparability across studies and laboratories. Moreover, concerns about assay specificity, cross-reactivity, and interference from endogenous substances may impact the accuracy and reliability of multiplex immunoassay measurements. Additionally, regulatory requirements for assay validation, quality control, and clinical utility assessment pose challenges for market entry and product commercialization. Addressing these barriers requires collaboration between industry stakeholders, regulatory agencies, and standards organizations to establish best practices and guidelines for multiplex immunoassay development and validation.

Market Opportunities:

The Multiplex Detection Immunoassay Market presents significant growth opportunities driven by technological innovations, market expansion, and application diversification. Emerging trends such as single-cell analysis, spatial profiling, and multi-omics integration offer new avenues for multiplex immunoassay technologies to address complex biological questions and disease mechanisms. The development of high-throughput immunoassay platforms, microfluidic devices, and point-of-care testing systems enables rapid and cost-effective analysis of biomarkers in clinical and research settings. Furthermore, the growing demand for companion diagnostics, immune monitoring, and patient stratification in precision medicine creates new market opportunities for multiplex immunoassay assays and platforms. Strategic partnerships, collaborations, and investments in research and development are essential to capitalize on emerging trends and sustain market leadership in the dynamic field of multiplex immunoassays.

Key Questions Answered in the Report:

  • What factors are driving the growth of the Multiplex Detection Immunoassay Market globally?
  • How are advancements in immunoassay technology and assay design reshaping the competitive landscape of multiplex immunoassays?
  • What are the key challenges and opportunities facing market participants in the multiplex immunoassay segment?
  • Which applications and end-user segments offer the highest growth potential for multiplex immunoassay products and services?
  • What strategies are leading companies employing to maintain their competitive edge and drive innovation in the market?

Competitive Intelligence and Business Strategy:

Leading players in the global Multiplex Detection Immunoassay Market, including diagnostic companies, biotechnology firms, and life sciences suppliers, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop next-generation multiplex immunoassay platforms, assays, and reagents tailored to specific clinical and research applications. Moreover, strategic collaborations with key opinion leaders, clinical research networks, and pharmaceutical partners enable companies to validate product performance, demonstrate clinical utility, and expand market reach. Furthermore, emphasis on customer support, technical training, and scientific education initiatives enhances brand reputation and customer loyalty in the competitive landscape of immunoassay technologies.

Key Companies Profiled:

  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • EMD Millipore (Merck KGaA.)
  • Becton, Dickinson and Company.
  • Microsynth AG
  • Quansys Biosciences Inc
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation.
  • Luminex Corporation

Multiplex Detection Immunoassay Market Research Segmentation:

Multiplex Detection Immunoassay Market By Technique

  • Nucleic Acid Based Technique
  • Protein Based Technique
  • Biosensor Based Technique

Multiplex Detection Immunoassay Market By Assay Type

  • Planar Assay
  • Blends Protein Arrays (Multiplexed ELISA)
  • Antibody Arrays
  • Bead-based Assay
  • Magnetic Bead-based
  • Non-magnetic Bead-based

Multiplex Detection Immunoassay Market By Application

  • Disease Testing
  • Infectious Disease Testing
  • Autoimmune Disease Testing
  • Other Diseases Testing
  • Food Contamination Testing
  • Research and Development
  • Veterinary Disease Testing

Multiplex Detection Immunoassay Market By End User

  • Pharmaceutical Companies
  • Clinical Research Organizations
  • Food & Beverages Companies
  • Academic Research Institutes
  • Diagnostic Centers
  • Biotechnology Centers

Multiplex Detection Immunoassay Market By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition

3. Market Dynamics

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
    • 3.2.1. Supply Side Drivers
    • 3.2.2. Demand Side Drivers
  • 3.3. Restraints
  • 3.4. Opportunities
  • 3.5. Trends

4. Market Context

  • 4.1. Regulatory Scenario
  • 4.2. PEST Analysis
  • 4.3. Technology Evolution

5. Global Multiplex Detection Immunoassay Market Value Analysis 2019-2023 and Forecast, 2022-2024

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2024
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Assay Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Assay Type, 2019-2023
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Assay Type, 2022 - 2024
    • 6.3.1. Planar Assay
      • 6.3.1.1. Blends Protein Arrays (Multiplexed ELISA)
      • 6.3.1.2. Antibody Arrays
    • 6.3.2. Bead-based Assay
      • 6.3.2.1. Magnetic Bead-based
      • 6.3.2.2. Non-magnetic Bead-based
  • 6.4. Market Attractiveness Analysis By Assay Type

7. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Technique

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Technique, 2019-2023
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2022 - 2024
    • 7.3.1. Nucleic Acid Based Technique
    • 7.3.2. Protein Based Technique
    • 7.3.3. Biosensor Based Technique
  • 7.4. Market Attractiveness Analysis By Technique

8. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Application

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 - 2024
    • 8.3.1. Disease Testing
      • 8.3.1.1. Infectious Disease Testing
      • 8.3.1.2. Autoimmune Disease Testing
      • 8.3.1.3. Other Diseases Testing
    • 8.3.2. Food Contamination Testing
    • 8.3.3. Research and Development
    • 8.3.4. Veterinary Disease Testing
  • 8.4. Market Attractiveness Analysis By Application

9. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2024
    • 9.3.1. Pharmaceutical Companies
    • 9.3.2. Clinical Research Organizations
    • 9.3.3. Food & Beverages Companies
    • 9.3.4. Academic Research Institutes
    • 9.3.5. Diagnostic Centers
    • 9.3.6. Biotechnology Centers
  • 9.4. Market Attractiveness Analysis By End User

10. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2024
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia
    • 10.3.5. East Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East & Africa
  • 10.4. Market Attractiveness Analysis By Region

11. North America Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2024
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Assay Type
    • 11.3.3. By Technique
    • 11.3.4. By Application
    • 11.3.5. By End User
  • 11.4. Market Attractiveness Analysis

12. Latin America Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2024
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Rest of Latin America
    • 12.3.2. By Assay Type
    • 12.3.3. By Technique
    • 12.3.4. By Application
    • 12.3.5. By End User
  • 12.4. Market Attractiveness Analysis

13. Europe Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2024
    • 13.3.1. By Country
      • 13.3.1.1. U.K
      • 13.3.1.2. Germany
      • 13.3.1.3. Italy
      • 13.3.1.4. Russia
      • 13.3.1.5. France
      • 13.3.1.6. Spain
      • 13.3.1.7. Rest of Europe
    • 13.3.2. By Assay Type
    • 13.3.3. By Technique
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis

14. South Asia Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 14.4.1. By Country
      • 14.4.1.1. India
      • 14.4.1.2. Thailand
      • 14.4.1.3. Indonesia
      • 14.4.1.4. Malaysia
      • 14.4.1.5. Rest of South Asia
    • 14.4.2. By Assay Type
    • 14.4.3. By Technique
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Market Attractiveness Analysis

15. East Asia Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
    • 15.4.2. By Assay Type
    • 15.4.3. By Technique
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Market Attractiveness Analysis

16. Oceania Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 16.4.1. By Country
      • 16.4.1.1. Australia
      • 16.4.1.2. New Zealand
    • 16.4.2. By Assay Type
    • 16.4.3. By Technique
    • 16.4.4. By Application
    • 16.4.5. End User
  • 16.5. Market Attractiveness Analysis

17. Middle East and Africa Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 17.4.1. By Country
      • 17.4.1.1. GCC Countries
      • 17.4.1.2. Turkey
      • 17.4.1.3. Northern Africa
      • 17.4.1.4. South Africa
      • 17.4.1.5. Rest of Middle East and Africa
    • 17.4.2. By Assay Type
    • 17.4.3. By Technique
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Market Attractiveness Analysis

18. Emerging Countries Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 18.1. Introduction
    • 18.1.1. Market Value Proportion Analysis, By Key Countries
    • 18.1.2. Global Vs. Country Growth Comparison
  • 18.2. France Multiplex Detection Immunoassay Market Analysis
    • 18.2.1. Introduction
    • 18.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.2.2.1. By Assay Type
      • 18.2.2.2. By Technique
      • 18.2.2.3. By Application
      • 18.2.2.4. By End User
  • 18.3. Spain Multiplex Detection Immunoassay Market Analysis
    • 18.3.1. Introduction
    • 18.3.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.3.2.1. By Assay Type
      • 18.3.2.2. By Technique
      • 18.3.2.3. By Application
      • 18.3.2.4. By End User
    • 18.3.3. Spain Multiplex Detection Immunoassay Market - Competition Landscape
  • 18.4. Japan Multiplex Detection Immunoassay Market Analysis
    • 18.4.1. Introduction
    • 18.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.4.2.1. By Assay Type
      • 18.4.2.2. By Technique
      • 18.4.2.3. By Application
      • 18.4.2.4. By End User

19. Competition Analysis

  • 19.1. Company Share Analysis
  • 19.2. Competition Dashboard
  • 19.3. Competition Deep Dive
    • 19.3.1. Bio-Rad Laboratories Inc.
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Product Offerings
      • 19.3.1.3. Financial Analysis
      • 19.3.1.4. Key Developments
      • 19.3.1.5. Strategy Overview
    • 19.3.2. Thermo Fisher Scientific
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Product Offerings
      • 19.3.2.3. Financial Analysis
      • 19.3.2.4. Key Developments
      • 19.3.2.5. Strategy Overview
    • 19.3.3. EMD Millipore (Merck KGaA.)
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Product Offerings
      • 19.3.3.3. Financial Analysis
      • 19.3.3.4. Key Developments
      • 19.3.3.5. Strategy Overview
    • 19.3.4. Becton, Dickinson and Company.
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Product Offerings
      • 19.3.4.3. Financial Analysis
      • 19.3.4.4. Key Developments
      • 19.3.4.5. Strategy Overview
    • 19.3.5. Microsynth AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Product Offerings
      • 19.3.5.3. Financial Analysis
      • 19.3.5.4. Key Developments
      • 19.3.5.5. Strategy Overview
    • 19.3.6. Quansys Biosciences Inc
      • 19.3.6.1. Company Overview
      • 19.3.6.2. Product Offerings
      • 19.3.6.3. Financial Analysis
      • 19.3.6.4. Key Developments
      • 19.3.6.5. Strategy Overview
    • 19.3.7. QIAGEN N.V.
      • 19.3.7.1. Company Overview
      • 19.3.7.2. Product Offerings
      • 19.3.7.3. Financial Analysis
      • 19.3.7.4. Key Developments
      • 19.3.7.5. Strategy Overview
    • 19.3.8. F. Hoffmann-La Roche Ltd.
      • 19.3.8.1. Company Overview
      • 19.3.8.2. Product Offerings
      • 19.3.8.3. Financial Analysis
      • 19.3.8.4. Key Developments
      • 19.3.8.5. Strategy Overview
    • 19.3.9. Danaher Corporation.
      • 19.3.9.1. Company Overview
      • 19.3.9.2. Product Offerings
      • 19.3.9.3. Financial Analysis
      • 19.3.9.4. Key Developments
      • 19.3.9.5. Strategy Overview
    • 19.3.10. Luminex Corporation
      • 19.3.10.1. Company Overview
      • 19.3.10.2. Product Offerings
      • 19.3.10.3. Financial Analysis
      • 19.3.10.4. Key Developments
      • 19.3.10.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology